Literature DB >> 8523301

Post-mastectomy seroma: a new look into the aetiology of an old problem.

S Kumar1, B Lal, M C Misra.   

Abstract

Postmastectomy seroma (PMS) remains an unresolved quandary as the risk factors for its formation have still not been identified. Sixty-four consecutive female patients undergoing Halsted mastectomy were prospectively studied for this purpose. The risk factors that were studied included age and weight, diabetes, hypertension, tumour (size and location) and nodal (positive or negative) status and the use of perioperative blood transfusion. Additionally, the effect of PMS on total hospital drainage (THD), post-operative hospital stay and other wound-related complications were assessed. The incidence of PMS in this study was 28%, and those patients with PMS were designated as group A while the remaining patients were designated as group B. Group A patients were significantly older (P < 0.02) and heavier (P < 0.05) than group B patients; also, there were significantly (P < 0.0001) greater number of hypertensive patients in group A than in group B. In terms of other risk factors the two groups were statistically similar. Group A patients had significantly greater (P < 0.01) amount of THD than group B patients. Although no septic complications were observed as a result of seroma, its presence significantly (P < 0.0001) lengthened the post-operative hospital stay in group A patients. It is concluded that (1) PMS is a common problem, (2) its occurrence significantly increases the post-operative hospital stay, and (3) hypertension is perhaps the most important risk factor for its causation. Hypertension contributes to seroma formation, probably by way of prolonged oozing from the large mastectomy wound.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8523301

Source DB:  PubMed          Journal:  J R Coll Surg Edinb        ISSN: 0035-8835


  31 in total

Review 1.  Breast lesions with high signal intensity on T1-weighted MR images.

Authors:  Irmak Durur-Subasi; Afak Durur-Karakaya; Fatih Alper; Adem Karaman; Rabia Mihriban Kılıc; Sare Sipal; Elif Demirci; Mufide Nuran Akcay
Journal:  Jpn J Radiol       Date:  2013-08-30       Impact factor: 2.374

2.  Comparison Study Between Scalpel and Electrocautery, in Causation of Seroma After Modified Radical Mastectomy.

Authors:  Rahulkumar N Chavan; Bhargav Chikkala; Pranab Mondal; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2016-05-14       Impact factor: 0.656

3.  Doxycycline Sclerotherapy to Manage Seroma Following Breast Cancer Surgery.

Authors:  Aravind Ramkumar
Journal:  Indian J Surg Oncol       Date:  2019-09-03

4.  Prevention of postoperative seromas with dead space obliteration: A case-control study.

Authors:  Johnathon M Aho; Terry P Nickerson; Cornelius A Thiels; Michel Saint-Cyr; David R Farley
Journal:  Int J Surg       Date:  2016-03-08       Impact factor: 6.071

5.  Potential risk factors for the development of seroma following mastectomy with axillary dissection.

Authors:  Xiao-Feng Pan; Jin-Liang Huan; Xian-Ju Qin
Journal:  Mol Clin Oncol       Date:  2014-09-25

6.  Seroma formation after mastectomy: pathogenesis and prevention.

Authors:  Sanjitha Sampathraju; Gabriel Rodrigues
Journal:  Indian J Surg Oncol       Date:  2011-04-02

7.  Prevalence, risk factors, and management of seroma formation after breast approach endoscopic thyroidectomy.

Authors:  Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Xiang-Min Zheng; Sheng Liu; Ming Qiu
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 8.  Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery.

Authors:  Muhammad S Sajid; Kristian H Hutson; Ignazio F Rapisarda; Riccardo Bonomi
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31

9.  The Use of TissuGlu® Surgical Adhesive for Mastectomy With or Without Lymphonodectomy.

Authors:  Ralf Ohlinger; Leonie Gieron; Rico Rutkowski; Thomas Kohlmann; Marek Zygmunt; Julia Unger
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

10.  Reducing Seroma Formation and Its Sequelae After Mastectomy by Closure of the Dead Space: A Multi-center, Double-Blind Randomized Controlled Trial (SAM-Trial).

Authors:  L de Rooij; S M J van Kuijk; R W Y Granzier; K F H Hintzen; C Heymans; L L B Theunissen; E M von Meyenfeldt; J A van Essen; E R M van Haaren; A Janssen; Y L J Vissers; G L Beets; J van Bastelaar
Journal:  Ann Surg Oncol       Date:  2020-10-19       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.